Patient and Practitioner Influences on the Placebo Effect in Irritable Bowel Syndrome

Objective: To determine whether placebo responses can be explained by characteristics of the patient, the practitioner, or their interpersonal interaction. Methods: We performed an analysis of videotape and psychometric data from a clinical trial of patients with irritable bowel syndrome who were treated with placebo acupuncture in either a warm empathic interaction (Augmented, n = 96), a neutral interaction (Limited, n = 97), or a waitlist control (Waitlist, n = 96). We examined the relationships between the placebo response and a) patient personality and demographics; b) treating practitioner; and c) the patient-practitioner interaction as captured on videotape and rated by the Psychotherapy Process Q-Set. Results: Patient extraversion, agreeableness, openness to experience, and female gender were associated with placebo response, but these effects held only in the augmented group. Regression analyses controlling for all other independent variables suggest that only extraversion is an independent predictor of placebo response. There were significant differences between practitioners in outcomes; this effect was twice as large as the effect attributable to treatment group assignment. Videotape analysis indicated that the augmented group fostered a treatment relationship similar to a prototype of an ideal healthcare interaction. Conclusions: Personality and gender influenced the placebo response, but only in the warm, empathic, augmented group. This suggests that, to the degree a placebo effect is evoked by the patient-practitioner relationship, personality characteristics of the patient will be associated with the placebo response. In addition, practitioners differed markedly in effectiveness, despite standardized interactions. We propose that the quality of the patient-practitioner interaction accounts for the significant difference between the groups in placebo response. IBS = irritable bowel syndrome; FFI = Five Factor Inventory; PQS = Psychotherapy Process Q-Set; M-PQS = Modified Psychotherapy Process Q-Set.

[1]  J. Ablon,et al.  How Expert Clinicians ' Prototypes of an Ideal Treatment Correlate with Outcome in Psychodynamic and Cognitive-Behavioral Therapy , 2008 .

[2]  Amy Baernstein,et al.  Educating for empathy , 2006, Journal of General Internal Medicine.

[3]  G. Woody,et al.  The Psychotherapist Matters: Comparison of Outcomes Across Twenty-Two Therapists and Seven Patient Samples , 1997 .

[4]  D. Drossman,et al.  Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome , 2008, BMJ : British Medical Journal.

[5]  Gary King,et al.  Amelia II: A Program for Missing Data , 2011 .

[6]  J. Ablon,et al.  Validity of controlled clinical trials of psychotherapy: findings from the NIMH Treatment of Depression Collaborative Research Program. , 2002, The American journal of psychiatry.

[7]  P. Enck,et al.  Psychobiology of the placebo response , 2006, Autonomic Neuroscience.

[8]  Kathy A Stepien,et al.  Educating for empathy. A review. , 2006, Journal of general internal medicine.

[9]  E. Jones.  Therapeutic Action: A Guide to Psychoanalytic Therapy , 2000 .

[10]  G. Dukes,et al.  Adequate relief as an endpoint in clinical trials in irritable bowel syndrome. , 1998, The Journal of international medical research.

[11]  B. Wampold,et al.  Estimating variability in outcomes attributable to therapists: a naturalistic study of outcomes in managed care. , 2005, Journal of consulting and clinical psychology.

[12]  M. Hyland,et al.  Consistency of the placebo effect. , 2008, Journal of psychosomatic research.

[13]  P. Lachenbruch.  Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .

[14]  K. Streitberger,et al.  Introducing a placebo needle into acupuncture research , 1998, The Lancet.

[15]  S. Ackerman,et al.  A review of therapist characteristics and techniques positively impacting the therapeutic alliance. , 2003, Clinical psychology review.

[16]  A. Hrõbjartsson,et al.  Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. , 2001, The New England journal of medicine.

[17]  P. Whorwell,et al.  The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress , 1997, Alimentary pharmacology & therapeutics.

[18]  J. Ablon,et al.  Psychotherapy process in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. , 1999, Journal of consulting and clinical psychology.

[19]  J. Auerbach.  Psychoanalytic books--reviews and discussions: Enrico Jones (2000). Therapeutic action: A guide to psychoanalytic therapy. Northvale, NJ: Jason Aronson: (302372005-015) , 2002 .

[20]  D. Erickson.  The placebo response. , 2009, The Journal of urology.

[21]  R. Rosenthal,et al.  Selective publication of antidepressant trials and its influence on apparent efficacy. , 2008, The New England journal of medicine.

[22]  D. Bolt,et al.  Therapist effects in psychotherapy: A random-effects modeling of the National Institute of Mental Health Treatment of Depression Collaborative Research Program data , 2006 .

[23]  H. Brody.  The placebo response. Recent research and implications for family medicine. , 2000, The Journal of family practice.

[24]  A. Mangel.  Personal view: adequate relief as a primary endpoint in irritable bowel syndrome , 2006, Alimentary pharmacology & therapeutics.

[25]  Roger B. Davis,et al.  Investigating placebo effects in irritable bowel syndrome: a novel research design. , 2006, Contemporary clinical trials.

[26]  W. Stiles,et al.  "Are all psychotherapies equivalent?". , 1986, The American psychologist.

[27]  P. Jhingran,et al.  Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome , 2001, American Journal of Gastroenterology.

[28]  R. Prinz,et al.  Treatment fidelity in outcome studies , 1991 .

[29]  K W Heaton,et al.  Functional bowel disorders and functional abdominal pain , 1999, Gut.

[30]  Roger B. Davis,et al.  Sham device v inert pill: randomised controlled trial of two placebo treatments , 2006, BMJ : British Medical Journal.

[31]  D. Berry,et al.  NEO Personality Inventory (NEO-PI-R) , 2010 .

[32]  B. Wampold.  The Great Psychotherapy Debate: Models, Methods, and Findings , 2001 .

[33]  R. Weiss,et al.  Variations in therapist effectiveness in the treatment of patients with substance use disorders: an empirical review. , 1994, Addiction.

[34]  P. Jhingran,et al.  Validation of Irritable Bowel Syndrome Global Improvement Scale: An Integrated Symptom End Point for Assessing Treatment Efficacy , 2003, Digestive Diseases and Sciences.

[35]  K. Thomas.  General practice consultations: is there any point in being positive? , 1987, British medical journal.

[36]  J. D. Frank,et al.  Eleventh Emil A. Gutheil memorial conference. Therapeutic factors in psychotherapy. , 1971, American journal of psychotherapy.

[37]  L. Lasagna,et al.  Do "placebo responders" exist? , 2008, Contemporary clinical trials.

[38]  K. Berbaum,et al.  Adjunctive non-pharmacological analgesia for invasive medical procedures: a randomised trial , 2000, The Lancet.

[39]  Fabrizio Benedetti,et al.  New Insights into the Placebo and Nocebo Responses , 2008, Neuron.

[40]  T. Kaptchuk,et al.  Do medical devices have enhanced placebo effects? , 2000, Journal of clinical epidemiology.

[41]  E. Blanchard,et al.  The effects of relaxation response meditation on the symptoms of irritable bowel syndrome: results of a controlled treatment study. , 2001, Behaviour research and therapy.

[42]  N. Pole,et al.  Using Psychodynamic, Cognitive Behavioral, and Control Mastery Prototypes to Predict Change: A New Look at an Old Paradigm for Long-Term Single-Case Research. , 2008 .

[43]  A. Horvath,et al.  Relation between Working Alliance and Outcome in Psychotherapy: A Meta-Analysis. , 1991 .

[44]  H. Engler,et al.  Named Series: Brain Mechanisms of Placebo Expectations and associations that heal: Immunomodulatory placebo eVects and its neurobiology , 2006 .

[45]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[46]  T. Kaptchuk,et al.  “Maybe I Made Up the Whole Thing”: Placebos and Patients’ Experiences in a Randomized Controlled Trial , 2009, Culture, medicine and psychiatry.

[47]  J. Kleijnen,et al.  Influence of context effects on health outcomes: a systematic review , 2001, The Lancet.

[48]  N. Pole,et al.  IDEAL CONTROL MASTERY TECHNIQUE CORRELATES WITH CHANGE IN A SINGLE CASE , 2002 .

[49]  D. Zuroff,et al.  Characteristics of effective therapists: further analyses of data from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. , 1996, Journal of consulting and clinical psychology.

[50]  B. Ohlsson,et al.  A course of instruction for women with irritable bowel syndrome. , 2006, Patient education and counseling.

[51]  G. Koch,et al.  Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. , 2003, Gastroenterology.

[52]  David Harley,et al.  The powerful placebo: from ancient priest to modern physician , 1999, BMJ.

[53]  K. Shaffer,et al.  Clinical competence assessment in radiology: introduction of an objective structured clinical examination in the medical school curriculum. , 2001, Academic radiology.

[54]  D. Drossman,et al.  Characterization of Health Related Quality of Life (HRQOL) for Patients With Functional Bowel Disorder (FBD) and Its Response to Treatment , 2007, The American Journal of Gastroenterology.

[55]  Judith A. Hall,et al.  Nonverbal behavior in clinician—patient interaction , 1995 .

[56]  J. Zubieta,et al.  Neurobiological Mechanisms of the Placebo Effect , 2005, The Journal of Neuroscience.

[57]  J. D. Frank.  Therapeutic Factors in Psychotherapy , 2006 .

[58]  J. Ablon,et al.  How Expert Clinicians' Prototypes of an Ideal Treatment Correlate with Outcome in Psychodynamic and Cognitive-Behavioral Therapy , 1998 .

[59]  J. Mintz,et al.  Implications of therapist effects for the design and analysis of comparative studies of psychotherapies. , 1991, Journal of consulting and clinical psychology.